Surgical Resection of Isolated Retroperitoneal Lymph Node Recurrence of Renal Cell Carcinoma Following Nephrectomy

Journal of Urology

Volumn 180, Issue 1, 2008, Pages 99-103

  Boorjian, Stephen A ^a   Crispen, Paul L ^a   Lohse, Christine M ^a   Leibovich, Bradley C ^a   Blute, Michael L ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

carcinoma; kidney; lymph nodes; neoplasm metastasis; nephrectomy; renal cell

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; NEPHRECTOMY; PRIORITY JOURNAL; RETROPERITONEAL CANCER; SURGICAL MORTALITY; SYSTEMIC THERAPY;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEPHRECTOMY; RETROPERITONEAL NEOPLASMS;

EID: 44649101896     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.03.025     Document Type: Article

References (20)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43
2. Pantuck A.J., Zisman A., and Belldegrun A.S. The changing natural history of renal cell carcinoma. J Urol 166 (2001) 1611
3. Kattan M.W., Reuter V., Motzer R.J., Katz J., and Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166 (2001) 63
4. Zisman A., Pantuck A.J., Wieder J., Chao D.H., Dorey F., Said J.W., et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 20 (2002) 4559
5. Sorbellini M., Kattan M.W., Synder M.E., Reuter V., Motzer R., Goetzl M., et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 173 (2005) 48
6. Kavolius J.P., Mastorakos D.P., Pavlovich C., Russo P., Burt M.E., and Brady M.S. Resection of metastatic renal cell carcinoma. J Clin Oncol 15 (1998) 2261
7. Itano N.B., Blute M.L., Spotts B., and Zincke H. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy. J Urol 164 (2000) 322
8. Master V.J., Gottschalk A.R., Kane C., and Carroll P.R. Management of isolated renal fossa recurrence following radical nephrectomy. J Urol 174 (2005) 473
9. Leibovich B.C., Cheville J.C., Lohse C.M., Zincke H., Frank I., Kwon E.D., et al. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. J Urol 174 (2005) 1759
10. Vasselli J.R., Yang J.C., Linehan W.M., White D.E., Rosenberg S.A., and Walther M.M. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. J Urol 166 (2001) 68
11. Pantuck A.J., Zisman A., Dorey F., Chao D.H., Han K.R., Said J., et al. Renal cell carcinoma with retroperitoneal lymph nodes: impact on survival and benefits of immunotherapy. Cancer 97 (2003) 2995
12. Canfield S.E., Kamat A.M., Sánchez-Ortiz R.F., Detry M., Swanson D.A., and Wood C.G. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome. J Urol 175 (2006) 864
13. Karakiewicz P.I., Trinh Q.D., Bhojani N., Bensalah K., Salomon L., de laTaille A., et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol 51 (2007) 1616
14. Tanguay S., Pisters L.L., Lawrence D.D., and Dinney C.P.N. Therapy of locally recurrent renal cell carcinoma after nephrectomy. J Urol 155 (1996) 26
15. Blom J.H.M., van Poppel H., Marechal J.M., Jacqmin D., Sylvester R., Schröder F.H., et al. Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC Randomized Phase III Protocol 30881. Eur Urol 36 (1999) 570
16. Blute M.L., Leibovich B.C., Cheville J.C., Lohse C.M., and Zincke H. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol 172 (2004) 465
17. Motzer R.J., Hutson T.E., Tomczak P., Michaelson M.D., Bukowski R.M., Rixe O., et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356 (2007) 115
18. Escudier B., Eisen T., Stadler W.M., Szczylik C., Oudard S., Siebels M., et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356 (2007) 125
19. DePrimo S.E., Bello C.L., Smeraglia J., Baum C.M., Spinella D., Rini B.I., et al. Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins. J Transl Med 5 (2007) 32
20. Majhail N.S., Urbain J.L., Albani J.M., Kanvinde M.H., Rice T.W., Novick A.C., et al. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma. J Clin Oncol 21 (2003) 3995